VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q79455138 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010857.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q79455138‏
024 ‎‡a 0000-0003-0750-3869‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q79455138‏
100 0 ‎‡a María I Albarrán‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a María I Albarrán‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae‏
670 ‎‡a Author's Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.‏
670 ‎‡a Author's Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases‏
670 ‎‡a Author's Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.‏
670 ‎‡a Author's Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors‏
670 ‎‡a Author's Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of anti-angiogenic therapies.‏
670 ‎‡a Author's Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.‏
670 ‎‡a Author's Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.‏
670 ‎‡a Author's Identification of novel PI3K inhibitors through a scaffold hopping strategy.‏
670 ‎‡a Author's Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.‏
909 ‎‡a (orcid) 0000000307503869‏ ‎‡9 1‏
919 ‎‡a identificationofnovelpi3kinhibitorsthroughascaffoldhoppingstrategy‏ ‎‡A Identification of novel PI3K inhibitors through a scaffold hopping strategy.‏ ‎‡9 1‏
919 ‎‡a rapididentificationofetp46992orallybioavailablepi3kinhibitorselectiveversusmtor‏ ‎‡A Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.‏ ‎‡9 1‏
919 ‎‡a newdestruxinasinhibitorofvacuolartypeh+atpaseofsaccharomycescerevisiae‏ ‎‡A A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae‏ ‎‡9 1‏
919 ‎‡a biologicalcharacterizationofetp46321aselectiveandefficaciousinhibitorofphosphoinositide3kinases‏ ‎‡A Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.‏ ‎‡9 1‏
919 ‎‡a chemicalinterrogationoffoxo3anucleartranslocationidentifiespotentandselectiveinhibitorsofphosphoinositide3kinases‏ ‎‡A Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases‏ ‎‡9 1‏
919 ‎‡a discoveryofmitogenactivatedproteinkinaseinteractingkinase1inhibitorsbyacomprehensivefragmentorientedvirtualscreeningapproach‏ ‎‡A Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.‏ ‎‡9 1‏
919 ‎‡a discoveryofnoveltriazolopyridazin3ylquinolinederivativesaspiminhibitors‏ ‎‡A Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors‏ ‎‡9 1‏
919 ‎‡a exomesequencingofplasmadnaportraysthemutationlandscapeofcolorectalcanceranddiscoversmutatedvegfr2receptorsasmodulatorsofantiangiogenictherapies‏ ‎‡A Exome sequencing of plasma DNA portrays the mutation landscape of colorectal cancer and discovers mutated VEGFR2 receptors as modulators of anti-angiogenic therapies.‏ ‎‡9 1‏
919 ‎‡a generationoftricyclicimidazopyrazinesasnovelpi3kinhibitorsbyapplicationofaconformationalrestrictionstrategy‏ ‎‡A Generation of tricyclic imidazo[1,2-a]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy.‏ ‎‡9 1‏
919 ‎‡a identificationofetp46321apotentandorallybioavailablepi3kαδinhibitor‏ ‎‡A Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.‏ ‎‡9 1‏
996 ‎‡2 BNE|XX844823
996 ‎‡2 SUDOC|135464528
996 ‎‡2 PTBNP|3258
996 ‎‡2 LC|n 2024019674
996 ‎‡2 RERO|A022432026
996 ‎‡2 ISNI|0000000093118980
996 ‎‡2 BNE|XX1637707
996 ‎‡2 BNE|XX5480218
996 ‎‡2 DNB|1157325270
996 ‎‡2 BNC|981058509190906706
996 ‎‡2 LC|no2011154053
996 ‎‡2 DNB|171692659
996 ‎‡2 BNC|981058520359606706
996 ‎‡2 BNC|981058524789206706
996 ‎‡2 NII|DA15003035
996 ‎‡2 ISNI|0000000061114838
996 ‎‡2 BNE|XX1725227
996 ‎‡2 RERO|A003425775
996 ‎‡2 ISNI|000000006043926X
996 ‎‡2 PLWABN|9810683240705606
996 ‎‡2 BNE|XX4819945
996 ‎‡2 CAOONL|ncf11237647
996 ‎‡2 BNE|XX1666851
996 ‎‡2 ISNI|0000000069519637
996 ‎‡2 BNF|16672097
996 ‎‡2 LC|no2010091870
996 ‎‡2 CAOONL|ncf13719631
996 ‎‡2 ISNI|0000000059433530
996 ‎‡2 ERRR|a11529593
996 ‎‡2 ISNI|0000000498660823
996 ‎‡2 LC|no2017135713
996 ‎‡2 LC|n 92069467
996 ‎‡2 ISNI|0000000060880995
996 ‎‡2 ISNI|0000000080464016
996 ‎‡2 SUDOC|057199132
996 ‎‡2 NTA|19199359X
996 ‎‡2 ISNI|0000000139105668
996 ‎‡2 ISNI|0000000067682430
996 ‎‡2 DNB|1057500542
996 ‎‡2 SUDOC|179848569
996 ‎‡2 SUDOC|151856648
996 ‎‡2 BNC|981060981472506706
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏